RU94014244A - PHARMACEUTICAL COMPOSITION FOR PERITONEAL DIALYSIS - Google Patents

PHARMACEUTICAL COMPOSITION FOR PERITONEAL DIALYSIS

Info

Publication number
RU94014244A
RU94014244A RU94014244/14A RU94014244A RU94014244A RU 94014244 A RU94014244 A RU 94014244A RU 94014244/14 A RU94014244/14 A RU 94014244/14A RU 94014244 A RU94014244 A RU 94014244A RU 94014244 A RU94014244 A RU 94014244A
Authority
RU
Russia
Prior art keywords
peritoneal dialysis
pharmaceutical composition
starch
peritoneal
dialysis
Prior art date
Application number
RU94014244/14A
Other languages
Russian (ru)
Other versions
RU2118531C1 (en
Inventor
Ферстер Харальд
Асскали Фатима
Нич Эрнст
Original Assignee
Левозан ГмбХ
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from DE4123001A external-priority patent/DE4123001A1/en
Application filed by Левозан ГмбХ filed Critical Левозан ГмбХ
Publication of RU94014244A publication Critical patent/RU94014244A/en
Application granted granted Critical
Publication of RU2118531C1 publication Critical patent/RU2118531C1/en

Links

Claims (1)

Фармацевтическая композиция, а также применение сложного эфира крахмала для приготовления такой фармацевтической композиции для перитонеального диализа, в частности для непрерывного абмулаторного перитонеального диализа (САРД), содержащей сложные эфиры крахмала, например ацетилкрахмал с молекулярным весом
Figure 00000001
100000 - 200000 дальтонов и молярным замещением 0,3 - 0,5. С помощью композиций можно осуществлять перитонеальный диализ без повреждения перитонеального эпителия. Никакого накопления крахмала в органах не наблюдается.
Pharmaceutical composition, as well as the use of starch ester for the preparation of such a pharmaceutical composition for peritoneal dialysis, in particular for continuous abmulatory peritoneal dialysis (SARD) containing starch esters, for example, molecular weight acetyl starch
Figure 00000001
100,000 to 200,000 daltons and a molar substitution of 0.3-0.5. With the help of compositions, peritoneal dialysis can be performed without damaging the peritoneal epithelium. There is no accumulation of starch in the organs.
RU94014244A 1991-07-11 1992-07-09 Pharmaceutical composition for peritoneal dialysis RU2118531C1 (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
DE4123001A DE4123001A1 (en) 1991-07-11 1991-07-11 PHARMACEUTICAL COMPOSITION FOR PERITONEAL DIALYSIS
DEP4123001.9 1991-07-11

Publications (2)

Publication Number Publication Date
RU94014244A true RU94014244A (en) 1996-01-27
RU2118531C1 RU2118531C1 (en) 1998-09-10

Family

ID=6435929

Family Applications (1)

Application Number Title Priority Date Filing Date
RU94014244A RU2118531C1 (en) 1991-07-11 1992-07-09 Pharmaceutical composition for peritoneal dialysis

Country Status (16)

Country Link
EP (1) EP0593590B1 (en)
JP (1) JPH07500024A (en)
AT (1) ATE130768T1 (en)
AU (1) AU657785B2 (en)
CA (1) CA2113164A1 (en)
CZ (1) CZ5894A3 (en)
DE (2) DE4123001A1 (en)
DK (1) DK0593590T3 (en)
ES (1) ES2081620T3 (en)
FI (1) FI940095A0 (en)
GR (1) GR3018997T3 (en)
HU (1) HUT66136A (en)
PT (1) PT100680A (en)
RU (1) RU2118531C1 (en)
SK (1) SK279744B6 (en)
WO (1) WO1993000939A1 (en)

Families Citing this family (13)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE4122999A1 (en) * 1991-07-11 1993-01-14 Laevosan Gmbh & Co Kg METABOLIZABLE PLASMA REPLACEMENT
DE4242926C2 (en) * 1992-12-18 1994-12-15 Fresenius Ag Dialysis solution for peritoneal dialysis
FI942686A0 (en) * 1994-06-07 1994-06-07 Alko Ab Oy Composition of the starch acetate with a variety of compounds, for the production and distribution
US5656292A (en) * 1994-06-07 1997-08-12 Alko Group Ltd. Composition for pH dependent controlled release of active ingredients and methods for producing it
CA2155910C (en) * 1995-08-11 1999-12-14 George Wu Biocompatible aqueous solution for use in continuous ambulatory peritoneal dialysis
US6770148B1 (en) 1998-12-04 2004-08-03 Baxter International Inc. Peritoneal dialysis solution containing modified icodextrins
DE19913757B4 (en) * 1999-03-26 2004-06-17 Audi Ag Method of making a riveted joint
DE10237442B4 (en) * 2002-08-16 2004-08-19 Fresenius Kabi Deutschland Gmbh Highly branched, low substituted starch products
EP1624936B1 (en) 2003-05-16 2009-10-28 Universite Laval Cns chloride modulation and uses thereof
US7053059B2 (en) 2003-07-25 2006-05-30 Baxter International Inc. Dialysis solutions with reduced levels of glucose degradation products
ES2636637T3 (en) * 2009-12-06 2017-10-06 B. Braun Melsungen Ag Mixtures of starch derivatives
DE102010012183A1 (en) * 2010-03-19 2011-09-22 Fresenius Medical Care Deutschland Gmbh Esterified polysaccharide osmotica
EP3381484A1 (en) * 2017-03-31 2018-10-03 Opterion Health AG Carbohydrate composition for dialysis

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB1476057A (en) * 1975-03-20 1977-06-10 Unicliffe Ltd Throat pastilles
DE3428201A1 (en) * 1984-07-31 1986-02-06 Laevosan-Gesellschaft mbH & Co. KG, Linz PERITONEAL DIALYSIS SOLUTIONS
DE4123000A1 (en) * 1991-07-11 1993-01-14 Laevosan Gmbh & Co Kg METHOD FOR PRODUCING STARCHESTERS FOR CLINICAL, IN PARTICULAR PARENTERAL APPLICATION

Similar Documents

Publication Publication Date Title
RU94014244A (en) PHARMACEUTICAL COMPOSITION FOR PERITONEAL DIALYSIS
PT861073E (en) STABILIZED THYROID HORMONE PREPARATIONS AND METHODS FOR PREPARING THEM
RU94016158A (en) POLYMERIC CONJUGAT, METHOD FOR ITS OBTAINING, PHARMACEUTICAL COMPOSITION
EP0340741A3 (en) Polyethylene glycol derivatives, modified peptides and production thereof
KR900012592A (en) Dental fillings
KR910016770A (en) Glycosaminoglycan-Modified Protein
ATE204179T1 (en) PHARMACEUTICAL COMPOSITIONS
ES2081620T3 (en) PHARMACEUTICAL COMPOSITION FOR PERITONEAL DIALYSIS.
KR900015718A (en) Osteoarthritis Treatment
KR880007069A (en) Triglyceride composition
FR2734481B1 (en) STABILIZED PSEUDO-EMULSIONS AND THEIR PREPARATION PROCESS
CA2133885A1 (en) Crystalline inclusion complex of diclofenac with beta-cyclodextrin
CA2057291A1 (en) A stable pharmaceutical composition of human calcitonin
ATE239042T1 (en) WATER SOLUBLE ARABINOGALACTAN DERIVATIZED WITH LIPOPHILIC GROUPS
HUP0100087A1 (en) Nucleosides analogues, the use thereof for producing medicaments useful against retroviral infections and hepatitis b virus and the same medicaments
EP0365957A3 (en) Combinations of a cellulose ester and a polymer, their preparation and their use
RU92016593A (en) NEW POLYPEPTIDE WITH LIPOPOLYSACCHARIDES AND THE PHARMACEUTICAL COMPOSITION FOR HIV INHIBITION ON THE BASIS
KR900014385A (en) Pharmaceutical treatment
FI940097A (en) Method of preparation for starch esters used clinically, especially parenterally
CA2021173A1 (en) Radioactive diagnostic agent
KR920009852A (en) Salts of glycosaminoglycans and esters of amino acids, preparation methods thereof, and pharmaceutical compositions containing such salts
RU2110281C1 (en) Blood plasma substituent
KR910004668A (en) Substances having a heparin phase structure and preparation method thereof
RU94004148A (en) COPOLYMERS OF METHACRYLIC ACID ESTERS AS FILM-FORMING COMPONENTS OF BONDING AND COATINGS
Haur Grosshadern Prize for Innovative Research in Urology 1994